Mr. Harper has extensive experience forming, advising and operating non-profit organizations as Chief General Counsel with the Las Vegas Police Protective Association and as outside counsel for the many entities delineated herein. He additionally, has done the same in the private sector in forming, advising and operating both private and publicly traded entities. He has formed over twenty public companies, in addition he has ample experience with securities filings.
CEO – John Harper
LATEST ENZYME BIOSYSTEMS PRESS RELEASE & NEWS
The management team of Enzymebiosystems (ENZB) announced they have moved further along the process of evaluating an enzyme compound which they believe has specific therapeutic value in fighting tumors. In an effort to evaluate this compound, management has had a series of meetings with various contract research organizations to enlist their expertise in performing animal studies. The research will study the use of a antitumor natural product called amooranin. Specifically, the two areas of this study will include: 1) an exam of the vitro cytotoxicity of amooranin against hepatocellular carcinoma cells, and 2) investigate the dose responsive antitumor actions of amooranin against chemically induced hepatic tumorgenesis in rats and dogs.
Management hopes the research will identify an enzyme compound that will lead to an Investigational New Drug application (IND) with the U.S. Federal Drug Association (FDA). It is still too early to determine if this project has any potential value for the company, and there are no assurances that the company will ever obtain an IND for this compound.